APA (7th ed.) Citation

E, B., J, S., W, H., J, M., S, D., & TE, G. (2026). Perioperative Outcomes from a Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial. Annals of surgical oncology, 33(7), 6185. https://doi.org/10.1245/s10434-026-19519-y

Chicago Style (17th ed.) Citation

E, Buckarma, Steadman J, Harmsen W, Mandrekar J, Daniel S, and Grotz TE. "Perioperative Outcomes from a Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial." Annals of Surgical Oncology 33, no. 7 (2026): 6185. https://doi.org/10.1245/s10434-026-19519-y.

MLA (9th ed.) Citation

E, Buckarma, et al. "Perioperative Outcomes from a Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial." Annals of Surgical Oncology, vol. 33, no. 7, 2026, p. 6185, https://doi.org/10.1245/s10434-026-19519-y.